Next Article in Journal
Population Reference Values for Serum Methylmalonic Acid Concentrations and Its Relationship with Age, Sex, Race-Ethnicity, Supplement Use, Kidney Function and Serum Vitamin B12 in the Post-Folic Acid Fortification Period
Previous Article in Journal
Malnutrition, Inflammation, Atherosclerosis Syndrome (MIA) and Diet Recommendations among End-Stage Renal Disease Patients Treated with Maintenance Hemodialysis
Open AccessArticle

Influence of Chitosan Treatment on Surrogate Serum Markers of Cholesterol Metabolism in Obese Subjects

1
Institute for Clinical Chemistry and Clinical Pharmacology, University Clinics of Bonn, D-53127 Bonn, Germany
2
Department of Radiology, University Clinics of Bonn, D-53127 Bonn, Germany
3
Department of Radiology, Neuroradiology, Sonography and Nuclear Medicine, Krankenhaus der Barmherzigen Brüder Trier, D-54292 Trier, Germany
4
Medizin & Service GmbH, Abt. Biostatistik, Boettcherstraße 10, D-09117 Chemnitz, Germany
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(1), 72; https://doi.org/10.3390/nu10010072
Received: 8 December 2017 / Revised: 5 January 2018 / Accepted: 9 January 2018 / Published: 11 January 2018
Chitosan treatment results in significantly lower serum low density lipoprotein (LDL) cholesterol concentrations. To assess the working mechanisms of chitosan, we measured serum surrogate markers of cholesterol absorption (campesterol, sitosterol, cholestanol), synthesis (lathosterol, lanosterol, desmosterol), and degradation to bile acids (7α-hydroxy-cholesterol, 27-hydroxy-cholesterol), corrected for cholesterol concentration (R_sterols). Over 12 weeks, 116 obese subjects (Body Mass Index, BMI 31.7, range 28.1–38.9 kg/m2) were studied under chitosan (n = 61) and placebo treatments (n = 55). The participants were briefly educated regarding improvement of nutrition quality and energy expenditure. Daily chitosan intake was 3200 mg. Serum LDL cholesterol concentration decreased significantly more (p = 0.0252) under chitosan (−8.67 ± 18.18 mg/dL, 5.6%) than under placebo treatment (−1.00 ± 24.22 mg/dL, 0.9%). This reduction was not associated with the expected greater decreases in markers of cholesterol absorption under chitosan treatment. Also, increases in markers of cholesterol synthesis and bile acid synthesis under chitosan treatment were not any greater than under placebo treatment. In conclusion, a significant selective reduction of serum LDL cholesterol under chitosan treatment is neither associated with a reduction of serum surrogate markers of cholesterol absorption, nor with increases of markers for cholesterol and bile acid synthesis. View Full-Text
Keywords: cholesterol synthesis; bile acid synthesis; cholesterol absorption; lathosterol; plant sterols; oxysterols; lipoproteins; lipid lowering; phytosterols; placebo cholesterol synthesis; bile acid synthesis; cholesterol absorption; lathosterol; plant sterols; oxysterols; lipoproteins; lipid lowering; phytosterols; placebo
Show Figures

Graphical abstract

MDPI and ACS Style

Lütjohann, D.; Marinova, M.; Wolter, K.; Willinek, W.; Bitterlich, N.; Coenen, M.; Coch, C.; Stellaard, F. Influence of Chitosan Treatment on Surrogate Serum Markers of Cholesterol Metabolism in Obese Subjects. Nutrients 2018, 10, 72.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop